GlassScriptPhysician profile
Nathan Hales
NPI 1053450304
$1,007.68
in general payments reported to CMS, 2019-2025
15 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.44 · 2020: $14.06 · 2021: $52.38 · 2023: $17.45 · 2024: $268 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860 · Education: $15.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.84 |
| Education | $15.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $367.35 | 2024-2025 | |
| Medtronic, INC. | $140.49 | 2025 | Propel |
| Regeneron Healthcare Solutions, INC. | $135.65 | 2024-2025 | Dupixent, Libtayo |
| Intuitive Surgical, INC. | $92.38 | 2019-2021 | |
| Depuy Synthes Sales INC. | $51.67 | 2024-2025 | Trumatch |
| Ars Pharmaceuticals Operations, INC. | $46.31 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $35.05 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $28.14 | 2019-2020 | |
| Lilly USA, LLC | $26.68 | 2025 | Zepbound |
| Glaxosmithkline, LLC. | $25.44 | 2024 | Nucala |
| Fisher & Paykel Healthcare INC | $17.45 | 2023 | Fisher & Paykel Healthcare |
| Tactile Systems Technology INC | $14.89 | 2024 | Flexitouch Plus, Entre Plus |
| Optinose US, INC. | $14.82 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $11.36 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Hales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.